Hypopigmentation: Clinical Trials

3 trials for Hypopigmentation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Unknown 3
Phase 21Unknown 1

Follow Hypopigmentation: new trials by email Literature Review of Hypopigmentation trials Research Report on Hypopigmentation

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment
Masitinib, Placebo, Best Supportive Care - Indolent Systemic Mastocytosis
Phase 3UnknownAB Science1402020-07-012023-05-06
Microneedling and Latanoprost in Acrofacial Vitiligo
Latanoprost, Microneedling - Vitiligo
Phase 2 / Phase 3UnknownSohag University702018-09-012018-08-28
Virus Early Transcription Factor (VETF) Multicenter Phototherapy Protocol
Sequential phototherapy, Continuous phototherapy - Vitiligo
Phase 3UnknownIstituti Fisioterapici Ospitalieri2002007-04-012010-06-02

Narrower conditions

Vitiligo (2)  ·  Blushing (1)  ·  Mastocytosis (1)  ·  Mastocytosis, Systemic (1)  ·  Piebaldism (1)  ·  Pruritus (1)

Broader conditions

Pigmentation Disorders (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Albinism (1)  ·  Amino Acid Metabolism, Inborn Errors (1)  ·  Behavior (1)  ·  Communication (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Eye Diseases, Hereditary (1)  ·  Genetic Diseases, Inborn (1)  ·  Immune System Diseases (1)  ·  Mast Cell Activation Disorders (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)

Interventions

Latanoprost (1)  ·  Percutaneous Collagen Induction (1)  ·  masitinib (1)

Sponsors

AB Science (1)  ·  Istituti Fisioterapici Ospitalieri (1)  ·  Sohag University (1)

Countries

France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  Ukraine (1)  ·  United Kingdom (1)

Top investigators

Cristina Bulai Livideanu, MD, MSc (1)  ·  Mauro Picardo, MD (1)  ·  Ramadan Saleh, MD (1)

Results publications

PMID 36048877

NIH funding

2016 (1)